Cite
HARVARD Citation
Yan, Q. et al. (2021). Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients. Emerging microbes & infections. 10 (1), pp. 1097-1111. [Online].